Home > Investor > Services > Events

Events

In order to provide maximum information to shareholders and potential investors, stakeholders and financial analysts, the management of "Sopharma" AD presents the Corporate Calendar for 2021 with the most important corporate events.

І. PERIODIC DISCLOSURES AND DUE DATES

2024
20 June 2024 Financial revenues for January-May 2024 Add to calendar
30 June 2024 Holding a Regular general meeting of shareholders of "Sopharma" AD. Add to calendar
22 July 2024 Financial revenues for January-June 2024 Add to calendar
30 July 2024 Individual financial statements for Q2 of 2024 Add to calendar
20 August 2024 Financial revenues for January-July 2024 Add to calendar
29 August 2024 Consolidated financial statements for Q2 of 2024 Add to calendar
20 September 2024 Financial revenues for January-August 2024 Add to calendar
21 October 2024 Financial revenues for January-September 2024 Add to calendar
30 October 2024 Individual financial statements for Q3 of 2024 Add to calendar
20 November 2024 Financial revenues for January-October 2024 Add to calendar
29 November 2024 Consolidated financial statements for Q3 of 2024 Add to calendar
20 December 2024 Financial revenues for January-November 2024 Add to calendar
2025
20 January 2025 Financial revenues for January-December 2024 Add to calendar
30 January 2025 Publication of Preliminary Annual Individual financial statements for 2024 Add to calendar
3 March 2025 Consolidated financial statements for Q4 of 2024 Add to calendar
20 March 2025 Financial revenues for January-February 2025 Add to calendar
22 March 2025 Financial revenues for January-March 2025 Add to calendar
31 March 2025 Publication of the Annual Individual Audit Report for 2024 Add to calendar
30 April 2025 Publication of the Annual Consolidated Audit Report for 2024 Add to calendar

Reminder service: select the events through the check box on the left column and, filling the field at the bottom page with the e-mail address, you will receive an alert 1 day before the event.

I agree for processing and storing of my personal data by Sopharma AD seated in Sofia, 5 Lachezar Stanchev Str., Sopharma Business Towers, building A, fl. 11, 1756 Sofia, in accordance with the Bulgarian Act on the Protection of Personal Data. I herby declare that my personal data given in the above form are authentic.

 

2024
30 May 2024 Consolidated financial statements for Q1 of 2024
20 May 2024 Financial revenues for January-April 2024
30 April 2024 Individual financial statements for Q1 of 2024
29 April 2024 Publication of the Annual Consolidated Audit Report for 2023
22 April 2024 Financial revenues for January-March 2024
29 March 2024 Publication of the Annual Individual Audit Report for 2023
20 March 2024 Financial revenues for January-February 2024
29 February 2024 Consolidated financial statements for Q4 of 2023
20 February 2024 Financial revenues for January 2024
30 January 2024 Publication of Preliminary Annual Individual financial statements for 2023
22 January 2024 Financial revenues for 2023
19 January 2024 Financial revenues for January-December 2023
2023
20 December 2023 Financial revenues for January-November 2023
29 November 2023 Consolidated financial statements for Q3 of 2023
20 November 2023 Financial revenues for January-October 2023
30 October 2023 Individual financial statements for Q3 of 2023
20 October 2023 Financial revenues for January-September 2023
20 September 2023 Financial revenues for January-August 2023
29 August 2023 Consolidated financial statements for Q2 of 2023
21 August 2023 Financial revenues for January-July 2023
31 July 2023 Individual financial statements for Q2 of 2023
20 July 2023 Financial revenues for January-June 2023
30 June 2023 Holding a Regular general meeting of shareholders of "Sopharma" AD
20 June 2023 Financial revenues for January-May 2023

* If there is a decision of the General Meeting of Shareholders.

**Preliminary date. Subject to change upon change of circumstances.

ІІ. DISCLOSURE OF INFORMATION ABOUT IRREGULAR EVENTS

EVENTDUE DATE
1. Decision by the Board of Directors Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
2. Changes in the Board of Directors or the representation of the Company The disclosure shall be made through the Minutes of the General Meeting, presented to the FSC and the regulated market within three business days from the date of its conduct. After entering this fact in the commercial register the disclosure shall be made by the end of the business day following the day of the discovery of the entry, but not later than  2 days after the entry in the Commercial Register.
3. Changes to the Articles of association The disclosure shall be made through the Minutes of the General Meeting, presented to the FSC and the regulated market within three business days from the date of its conduct. After entering this fact in the commercial register the disclosure shall be made by the end of the business day following the day of the discovery of the entry, but not later than 2 days after the entry in the Commercial Register.
4. Change in the persons controlling the Company Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
5. Decision for transformation of the Company and implementation of the transformation; structural changes in the company Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
6. Initiation of liquidation and all significant stages related to the liquidation Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
7. Initiation of bankruptcy of the Company or its subsidiary and all significant stages related to the bankruptcy Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
8. Acquisition, lease or disposition of assets of great value under art. 114, par. 1, item 1 POSA Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
9. Decision for entering in, termination and cancellation of а joint venture agreement Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
10. Changing the auditors of the Company and reasons for the change Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
11. Disclosure of the net profit of the Company Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
12. Significant losses and the reasons for them Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
13. Unforeseen or unexpected circumstance of an extraordinary nature, resulting in damages by the Company or a subsidiary amounting to three percent or more of the Company's equity. Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
14. Modified audit report Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
15. Decision of the General Меетинг on the type and amount of the dividend and the terms and conditions for its payment Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
16. Occurrence of an obligation which is essential for the Company or its subsidiary, including any unfulfillment or increase of the obligation. Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
17. Occurrence of a claim that is essential for the Company, with indication of its maturity Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
18. Liquidity problems and measures for financial support Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
19. Increase or decrease of share capital Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
20. Confirmation of negotiations for acquisition of the Company Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
21. Conclusion or performance of essential contracts, which do not relate to the ordinary business of the Company Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
22. Opinion of the governing body in connection with a tender offer Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
23. Termination or substantial reduction of relations with clients, who form at least 10 percent of the revenues of the Company for the last three years. Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
24. Introduction of new products and developments on the market Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
25. Large orders (amounting to over 10 percent of the average earnings of the Company for last three years) Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
26. Development and / or change in the volume of orders and the utilization of the production capacity Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
27. Ceasing sales of a product, forming a significant part of the company's revenue Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
28. Purchase of patent Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
29. Reception, temporary suspension of use, withdrawal of permission to operate (license). Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
30. Initiation or termination of a court or arbitration proceedings relating to claims or liabilities of the company or its subsidiary, with the price of the claim at least 10 percent of the company's equity Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
31. Purchase, sale or pledge of shares in companies by the issuer or their subsidiary Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
32. Prepared forecast by the issuer for their financial results for their economic group, if it is decided the forecast to be publicly disclosed Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.
33. Awarding or change of a rating commissioned by the issuer Immediately but not later than the end of the business day following the decision or the discovery of the particular fact.